Rituximab Provides Steroid-Sparing Therapy in New-Onset Chronic Graft-Versus-Host Disease

Biology of Blood and Marrow Transplantation - Netherlands
doi 10.1016/j.bbmt.2012.11.081
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Late Onset and Protracted Course of Steroid Refractory Chronic Graft-Versus-Host Disease

Case Reports in Hematology
2015English

Combination of Bortezomib Plus Ruxolitinib in Steroid-Refractory Chronic Graft-Versus-Host Disease

Bone Marrow Transplantation
TransplantationHematology
2018English

Response to Thalidomide Therapy in Refractory Chronic Graft-Versus-Host Disease

Bone Marrow Transplantation
TransplantationHematology
2000English

Tocilizumab for Steroid Refractory Acute Graft-Versus-Host Disease

Leukemia and Lymphoma
Cancer ResearchOncologyHematology
2015English

Dasatinib as Salvage Therapy for Steroid Refractory and Imatinib Resistant or Intolerant Sclerotic Chronic Graft-Versus-Host Disease

Biology of Blood and Marrow Transplantation
TransplantationHematology
2012English

Lymphocyte Dysfunction in Chronic Graft-Versus-Host Disease

Blood
BiochemistryImmunologyCell BiologyHematology
1981English

Treatment of Chronic Graft-Versus-Host Disease in 2011

Current Opinion in Hematology
Hematology
2011English

Topical Corticosteroid Therapy for Cicatricial Conjunctivitis Associated With Chronic Graft-Versus-Host Disease

Bone Marrow Transplantation
TransplantationHematology
2004English

Sirolimus for Treatment of Steroid-Refractory Acute Graft-Versus-Host Disease

Bone Marrow Transplantation
TransplantationHematology
2009English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy